Clinical Trials for Long COVID Treatment

The Microvascular Research Foundation (MVRF) is at the forefront of pioneering research into Long COVID and Spike Protein Injury. As part of our commitment to advancing understanding and treatment, we are excited to announce the commencement of clinical trials for Long COVID treatment in 2024.

Why Participate in Our Clinical Trials?

  1. Contribute to Groundbreaking Research: By participating, you'll be directly contributing to the advancement of knowledge and potential treatments for Long COVID.
  2. Access to Innovative Treatments: Participants will have the opportunity to access and benefit from the latest treatment protocols under investigation.
  3. Expert Care: Our dedicated team of physicians and researchers will ensure that participants receive the highest standard of care throughout the trial.

Stay Informed and Get Involved

While specific details of the trials are still under development, we encourage interested individuals to stay informed about enrollment opportunities and progress updates.

  1. Regular Updates: By joining our community or signing up for updates, you'll receive timely notifications about trial enrollment, progress, and findings.
  2. Safety First: All our clinical trials adhere to strict ethical and safety guidelines to ensure the well-being of participants.
  3. Your Participation Matters: Whether you're considering participating or simply want to stay informed, your involvement is crucial in helping us understand and combat Long COVID.

Stay Updated on Our Clinical Trials

Sign up below to receive timely updates on our clinical trials, including enrollment opportunities and progress reports.

500 characters left